Sensex dips 155 points as record Covid cases weigh on indices; Pharma stocks up
Snapping their 3-day winning streak, domestic equity markets traded range-bound in the negative territory on Friday, with a few episodes of gains. Amid mixed global cues and record Covid-19 cases back home, coupled with reports of a vaccine supply crunch, the benchmark indices dropped 0.3 per cent today.
Among headline indices, the S&P BSE Sensex ended the day at 49,591 level, down 155 points. 50 per cent of the constituents ended the day in the red with Bajaj Finance (down 3 per cent), Ultratech Cement, NTPC, ICICI Bank, Axis Bank, IndusInd Bank, and Reliance Industries leading the list of losers. On the upside, Sun Pharma, HUL, Tech Mahindra, Titan Company, Dr Reddy’s Labs, and HCL Tech were the top gainers on the index, up in the range of 1 per cent to 3.5 per cent.
On the NSE, the 50-share barometer settled at 14,835 levels, down 39 points dragged down by UPL, Tata Steel, Coal India, and Axis Bank.
Trends in the broader markets were mixed as the S&P BSE SmallCap index closed 0.7 per cent higher while the S&P BSE MidCap index dipped 0.07 per cent.
The SmallCap index hit fresh record peak of 21,667, for second day in a row on the back of gains in Srei Infra, Butterfly Gandhimathi, Kilitch Drugs, Subex, Bank of Maharashtra, Aarti Surfactants, Vimta Labs, and Sasken Technologies.
Sectorally, investors appeared to be defensive with the Nifty Pharma index ending over 3 per cent up. The Nifty IT and FMCG indices, meanwhile, settled 0.8 per cent higher each.
On the downside, the Nifty Bank, Private Bank, and Auto indices slipped up to 1 per cent.
